Prevention & Chronic Conditions


Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Related Articles


Dyslipidaemia in the Real World

Ricardo Lopez Santi, Felipe Martínez, Adrian Baranchuk,


Citation: European Cardiology Review 2021;16:e16.

Anti-inflammatory Treatment and Cardiovascular Outcomes

Alberto Lorenzatti,


Citation: European Cardiology Review 2021;16:e15.

APSC Consensus on Optimising CV Outcomes in T2D

Jack Wei Chieh Tan, David Sim, Junya Ako,


Citation: European Cardiology Review 2021;16:e14.

Inflammation in Coronary Epicardial and Microvascular Dysfunction

Shigeo Godo, Jun Takahashi, Satoshi Yasuda,


Citation: European Cardiology Review 2021;16:e13.